The goal of this study was to develop and validate clinical prediction rules for bacteremia and subtypes of bacteremia in patients with sepsis syndrome. Thus, a prospective cohort study, including a stratified random sample of 1342 episodes of sepsis syndrome, was done in eight academic tertiary care hospitals. The derivation set included 881 episodes, and the validation set included 461. Main outcome measures were bacteremia caused by any organism, gram-negative rods, gram-positive cocci, and fungal bloodstream infection. The spread in probability between low-and high-risk groups in the derivation sets was from 14.5% to 60.6% for bacteremia of any type, from 9.8% to 32.8% for gram-positive bacteremia, from 5.3% to 41.9% for gram-negative bacteremia, and from 0.6% to 26.1% for fungemia. Because the model for gram-positive bacteremia performed poorly, a model predicting Staphylococcus aureus bacteremia was developed; it performed better, with a low-to high-risk spread of from 2.6% to 21.0%. The prediction models allow stratification of patients according to risk of bloodstream infections; their clinical utility remains to be demonstrated.
Sepsis is a serious condition, with a reported mortality of ever, it seems likely that at least one of the novel therapies currently being developed will prove effective. 35% -60% [1 -3] , and estimates suggest that there are For these agents to be maximally effective, basic science Ç500,000 cases/year in the United States, making it the 13th research suggests that they should be given as soon as possible leading cause of death [4] . Despite the use of increasingly after the onset of sepsis [7] . An important problem has been that advanced therapeutic technology for its treatment, there has most patients with sepsis syndrome do not have bacteremia, and been little change in mortality over time. Because of this, subsome do not even have a serious bacterial infection. Thus, there stantial effort has been directed toward developing novel agents is substantial interest in identifying groups of patients who are directed at different levels in the sepsis cascade; such therapies particularly likely to benefit from novel therapies, some of hold substantial potential for reducing mortality in this frewhich would only be expected to be effective against specific quently fatal condition [5] . However, these agents require large types of organisms. investments by pharmaceutical and biotechnology companies This goal might be accomplished by using a combination of and, thus, will be expensive [6] . For example, one such drug clinical data to develop models for identifying patients likely that was released in Europe, the monoclonal antibody HA-1A, to benefit from a novel therapy effective against a particular was priced at $3000 -4000 per dose [6] . To date, no novel group of organisms, such as gram-negative bacteria. These therapy has been shown to be clearly efficacious [5, 7] . Howmodels could also be supplemented by a rapid diagnostic test or tests, such as measurement of endotoxin or cytokine levels [8, 9] . Such models, if sufficiently discriminatory and validated, tional variables. We then undertook a prospective multicenter tive infection was considered present if the site was the respiratory cohort study [10] , collecting data on these and many other tract, the skin, or a wound, if the infection was device-related, if
variables. The goals of this part of the study were to develop the patient indicated a strong suspicion of bacteremia on the basis of the clinical picture (e.g., presence of fever, chills, and hypotension without another obvious etiology) but no focal site could be identified. Focal fungal infection at onset was considered present
Methods
only if a culture or Gram's stain revealed fungi. Acute abdomen Patient population. All participating centers were members of was defined as presence of rebound tenderness or guarding of at the Academic Medical Center Consortium. All 8 centers were large least a moderate degree. tertiary care centers, with Ç18,800-43,700 admissions annually Data collection. Surveyors recorded the presence of all screen- [10] . Patient enrollment occurred between January 1993 and April ing criteria every day that a patient was a valid member of the 1994.
surveillance group [10] . If screening criteria were met, the patient Patients surveyed represented a stratified random sample of pawas enrolled as a case, and detailed information, including all the tients in or not in intensive care units (ICUs) and with either a potential predictors of bacteremia and subtypes, were prospectively positive or negative blood culture, as previously described [10] .
abstracted from the medical record. Additional data, including inIn addition, data were obtained for all patients who died in an formation about whether bacteremia or infection was indeed presemergency department or an ICU and for all patients who received ent in the initial episode and information about the outcome and a novel therapy for sepsis syndrome.
treatment of the episode, were gathered 28 days after entry. A randomly selected subset of sepsis episodes, the derivation Factors evaluated as potential predictors included variables idenset, was used to derive clinical prediction rules. These rules were tified as correlates of bacteremia in previous analyses [14] [15] [16] [17] and then validated (tested for accuracy) in the remaining episodes, the variables suggested by members of the study group. The following validation set. The split between derivation and validation sets was five types of variables were assessed for association with bactertwo-thirds to one-third [11] ; the same sets were used for all four emia of any type as assessed at sepsis onset: (1) historic factors, rules developed.
including the presence of shaking chills, liver disease (cirrhosis, Definitions. Patients were enrolled if they met the prospecchronic hepatitis, or hepatic failure), diabetes, or bowel perforation tively derived definitions. Sepsis syndrome was defined as pre-(during current admission), intravenous drug abuse, or history of viously described [10], using a modification of the criteria develbacteremia or organ transplantation (bone marrow, liver, heart, oped by Bone [12] . Bloodstream infection was defined as any kidney, lung, or small bowel); (2) physical examination findings, event meeting the Centers for Disease Control and Prevention's including elevated temperature, presence of hypotension, maxidefinition of bloodstream infection occurring within 24 h before mum pulse rate, acute abdomen, presence of confusion or delirium, or 48 h after the onset of sepsis syndrome [13] . For all bloodstream low urine output (õ30 mL/h for 2 h); (3) laboratory findings, infections, the culture results were reviewed by a study investigaincluding the presence of pyuria (mean leukocyte count §4/hightor. Prior to development of the predictive models, each episode power field in urine), elevated leukocyte count, presence of neutrowas classified according to whether any or only a gram-negative penia, percent bands ú12, decreased platelet count, presence of organism, any or only a gram-positive organism, or any or only a renal failure (creatinine §3 mg/dL, on dialysis, or acute renal fungal bloodstream infection was present. Herein, we often use failure noted in chart by a physician within 24 h of onset), presence the term ''bacteremia'' to refer to bloodstream infection involving of hyperglycemia (glucose §250 mg/dL), low systemic vascular either bacteria or fungi, as there is no convenient term encomresistance (£900 dyne-s-cm 05 ); (4) treatment factors, including passing both. The initial rule developed to predict gram-positive immunosuppressive drug therapy, location at onset (ICU, emerbacteremia performed poorly. We hypothesized that this might gency department, or general care unit), absence of antibiotic therhave been due to the heterogeneity of infections produced by these apy, antibiotic therapy for ú4 days before onset, number of antibiorganisms, and because Staphylococcus aureus was responsible otics received prior to onset during hospitalization, whether using for Ç40% of the episodes of gram-positive bacteremia, we develvasopressors, presence of a Hickman catheter, presence of a Foley oped a separate rule predicting the presence of S. aureus bactercatheter for a prolonged period, and whether receiving mechanical emia.
ventilation; and (5) severity of underlying disease and comorbidity. Among candidate predictors of bacteremia, documented focal Severity was assessed by use of the APACHE II and III scores infection was considered present if a culture from a usually sterile [18] [19] [20] , the SAPS (simplified acute physiology) II score [21] , the site was already positive at the time of onset of sepsis syndrome.
MPM (mortality probability models) II score [22] , and a modificaSuspected focal infection was considered present if there was a tion of McCabe and Jackson's scale in which patients were stranote in the patient's chart indicating a strong suspicion of focal tified into 3 groups, the rapidly fatal group (ú50% predicted infection (e.g., cellulitis or perforated viscus) and antibiotics had chance of fatality within 1 month, secondary to any underlying already been or were being started. Suspected gram-negative infecdisease), the eventually fatal group (ú50% predicted chance of fatality within 5 years from underlying disease), and nonfatal (no tion was considered present if the site was the urinary tract, bowel, underlying disease likely to be fatal within 5 years) [16] . In the patient can thus be determined by adding the points for each of the significant predictor variables. analyses, data are presented only using the sepsis-specific APACHE III, the SAPS II, and the modification of McCabe and
The performance of models was tested in the validation sets. Discriminatory performance of the model in the derivation set and Jackson's scale; the first two scores best predict mortality in this data set (Hibberd P, unpublished data), and the latter was inexpenthe validation set were compared using receiver-operating characteristic (ROC) curve analysis [25, 26] , and calibration performance sive to assess in comparison. Comorbidity was assessed by use of the Charlson comorbidity score [23] .
was assessed by plotting observed and predicted event frequencies by risk group as derived from logistic regression analysis [27] . Variables evaluated for association with subtypes of bacteremia included all of the above. In addition, variables for gram-negative
The ROC curve plots sensitivity against 1 minus specificity, using a range of ''cut-off'' values for a positive prediction. The ROC bacteremia included documented or presumed focal gram-negative infection, presence of a biliary stent, and history of gram-negative curves in this case thus describe the relationship between the truepositive and false-positive predictions of bacteremia. The area unbacteremia. Variables for gram-positive bacteremia included documented or presumed focal gram-positive infection and history of der the curve is a measure of the accuracy of discrimination of the rules' predictions; it would be 0.5 by chance alone, and ingram-positive bacteremia. Variables for S. aureus bacteremia included documented or presumed S. aureus infection, and variables creases toward 1 as the accuracy of the rule improves. To make the models easier to interpret, likelihood ratios were derived for for fungal bloodstream infection included isolation of fungus from another site and history of fungal bloodstream infection.
each clinically relevant stratum; the likelihood ratio for a test result is the ratio of its probability of occurrence if the disease is present Analysis. The primary issue of interest in this analysis was to optimize clinical decision-making at the time when novel therapy (true-positive rate) to its probability of occurrence if the disease is absent (false-positive rate) [28] . might be considered; therefore, the unit of analysis chosen was the episode of sepsis syndrome. Similarly, only information available at the time of onset of sepsis was eligible for entry into the
Results
predictive models, although data that became available within the following 6 h were collected and used in the mortality analyses
The dataset included 1342 episodes of sepsis syndrome, over half the patients were male, Ç60% were on medical serare weighted, including the multivariate analyses. In particular, only 10% of non-ICU patients with negative blood cultures were sampled, so cases in this group, compared with ICU patients, received a weight of 3.8. with three variables, with coefficients of 0.5, 0.7, and 1.2, the first characteristics differed between sets except that weighted % of patients in two variables would be assigned a score of 1, and the third variable intensive care unit at onset of sepsis was lower in derivation set than in validation set (P õ .02).
would be assigned a score of 2. The risk score for an individual / 9d3b$$de08 10-30-97 12:14:34 jinfa UC: J Infect between the 2 groups, except that the weighted percent of
Staphylococcus aureus 45 (16.8) patients in ICUs at the onset of sepsis was lower in the derivaStaphylococcus epidermis 26 (11.1) tion set than in the validation set (52.5% vs. 60.4%; P Å .02).
Enterococcus species 21 (6.2) In the derivation set, 283 (26.6%) of the episodes were asso- was documented by a positive culture from a normally sterile site (54.7% of episodes), compared with only 39.7% in which it was presumed but not documented (e.g., cellulitis). Each episode was also categorized according to the specific any bacteremia at the P õ .10 level (table 4) , with the strongest clinical correlates being presence of a suspected or documented type of organism present (table 3) . Gram-positive cocci accounted for 42.2% of the episodes, with the two leading types infection at onset of sepsis (P õ .001) and several antibiotic factors, including absence of current antibiotic therapy (P õ being S. aureus (17.1%) and coagulase-negative staphylococci (11.1%). Gram-negative rods accounted for 33.2% of all bacter-.001). Patients in ICUs at onset were less likely to be bacteremic (P õ .001), while those in the emergency department had a emic episodes; pseudomonal bacteremia accounted for about one-fifth of these. Most of the episodes of fungal bloodstream higher risk of bacteremia (P õ .004). Among severity and comorbidity measures, neither the APACHE III nor the SAPS infection were caused by Candida species. Polymicrobial infections accounted for 10.5% of the episodes.
II score nor the Charlson comorbidity index was correlated with the presence of bacteremia. Univariate correlates of bloodstream infection. In univariate analyses, 14 variables were correlated with the presence of There were 6 significant correlates of gram-positive bacteremia. The strongest clinical correlate was suspected or documented focal infection with gram-positive cocci at onset (P õ NOTE. All %s weighted by sampling fraction. ICU, intensive care unit; SVR, systemic vascular resistance; TPN, total parenteral nutrition; SAPS, simplified acute physiology score.
* Sites for suspected gram-negative rods at time of onset: urinary tract, bowel, biliary, other intraabdominal sites. Sites for suspected gram-positive cocci at time of onset: respiratory tract, skin, wound, device-related, endocarditis, infection site unknown.
† Shaking chills or rigor on physical examination. ‡ Defined as cirrhosis with or without portal hypertension, chronic hepatitis within last 6 months, hepatic failure with coma or encephalopathy within last 6 months.
§ Urine output £30 mL/h for 2 h. x Bone marrow, liver, heart, renal, lung, or small bowel transplant.
were absence of antibiotic therapy at onset and suspected or the patients, a model using S. aureus bacteremia as the outcome was developed. Independent predictors were suspected or docudocumented infection at onset. Had we excluded absence of antibiotic therapy at onset, the model would have included mented focal infection with S. aureus at onset, hemodialysis, and mechanical ventilation at sepsis onset. presence of chills and elevated band count, while presence of focal abdominal signs would have dropped out.
The independent predictors of gram-negative bacteremia were different; they included use of total parenteral nutrition Predictors of bacteremia caused by gram-positive cocci were intravenous drug abuse and suspected or documented focal before onset, absence of antibiotic therapy before onset, history of gram-negative bacteremia, presence of a Hickman catheter, infection with gram-positive cocci at onset (table 5). Because it was not possible to develop a model that adequately stratified focal abdominal signs, and presence of chills (table 5) . † Defined as cirrhosis with or without portal hypertension, chronic hepatitis within last 6 months, hepatic failure with coma or encephalopathy within last 6 months.
The factors predicting fungal bloodstream infection were however, is that 30% of episodes fall into group 3, which has a probability of bacteremia after the test that is similar to the presence of a documented (as determined by positive culture or microscopy) non-bloodstream fungal infection, pyuria, any pretest probability (likelihood ratio, 0.9). The remaining 70% of the cases could, however, be placed into groups with higher liver disease, or a Hickman catheter; bowel perforation; or altered mental status within 24 h (table 5). Because of the small and lower risks. Calibration performance of the model was good ( figure 3) . number of outcomes, P õ .10 was used as the threshold for entering the model; a threshold of P õ .05 only permitted entry
The rule for gram-positive bacteremia was the least discriminatory of the four rules, with a spread in probability of of patients with documented fungal infection.
Clinical prediction rules. As shown in table 6, the predicfrom 9.8% to 32.8% in the derivation set. The ROC areas were 0.62 { 0.03 in the validation set and 0.60 { 0.04 in tion rule for presence of any bacteremia stratified episodes into risks ranging from 14.5% to 60.6% in the derivation set; 20% the derivation set (data not shown); there was no significant difference in ROC areas between the sets. A rule using S. of the bacteremia episodes were in the 2 lowest-risk groups. The rule performed comparably well in the validation set (ROC aureus bacteremia as the outcome had an ROC area of 0.70 { 0.04 in the derivation set and 0.74 { 0.05 in the validation area, 0.69 { 0.02 in derivation set vs. 0.67 { 0.03 in validation set; figure 1 ). The distribution of episodes and cases across the set ( figure 1) . Most of the cases were placed in the 2 groups at highest risk (figure 2). risk groups is shown in figure 2 . A problem with this rule, / 9d3b$$de08 10-30-97 12:14:34 jinfa UC: J Infect NOTE. Data are no. (weighted %), except for LRs (likelihood ratios), which were calculated from combined derivation and validation sets.
The gram-negative bacteremia rule achieved a spread of the highest-risk groups, the calibration curves show that the observed probabilities are somewhat higher than predicted from 5.3% to 41.9% in the derivation set. In the validation set, the ROC area was 0.70 { 0.03, versus 0.67 { 0.04 in ( figure 3 ). The rule for predicting fungemia performed well in both the derivation set ( figure 1 ). However, in the validation set, two anomalies occurred. First, the risk in the group with a the derivation and validation sets. In the derivation set, it achieved a spread in risk from 0.6% to 26.1% between the risk score of 1 (group 2) had a higher probability of bacteremia (20.3%) than the group with a risk score of 2 (group lowest-and highest-risk groups. Correspondingly, this rule had the highest ROC areas: 0.82 { 0.05 in the derivation 3; 17.7%), and group 4 also had a higher probability of bacteremia (32.5%) than did group 5 (24.8%). Nonetheless, set and 0.75 { 0.08 in the validation set ( figure 1 ). Moreover, when the 2 highest-risk groups were combined in the validathis rule may be quite useful because 52% of the validation set fell into the lowest-risk group, which had only a 5.7% tion set, the rule identified a small population (only 18% of the validation set), which included 13 of the 19 cases; the probability of gram-negative bacteremia. In addition, the rule identified small high-risk groups; the 2 highest-risk groups risk of fungemia was very low in the remaining 82% of episodes. This reflects in large part the strength of the associhad likelihood ratios of 2.5 (group 4) and 5.9 (group 5). For Figure 1 . Receiver-operating characteristic curves for derivation set (ᮀ) and validation set () in study to determine prediction rules for bacteremia in sepsis. Dashed line represents test of no discriminative ability. P is probability that area of derivation curve is not greater than area of validation curve.
/ 9d3b$$de08
10-30-97 12:14:34 jinfa UC: J Infect Figure 2 . Distribution of episodes across risk groups in each of 4 prediction models in study to determine prediction rules for bacteremia in sepsis. Black columns, % of total episodes of sepsis syndrome in group; stippled columns, % of total bacteremia cases in group. Derivation and validation sets are combined.
ation between positive fungal cultures (other than bloodrisk groups. The rules for gram-negative bacteremia and fungemia may be most useful clinically. For gram-negative stream) at sepsis onset and fungemia. bacteremia, the rule identified a group comprising 52% of the patients in the validation set with only a 6% probability of Discussion gram-negative bacteremia and a much smaller group with a ú20% probability of gram-negative bacteremia. For fungemia, In this study, we determined the frequency of bacteremia in patients with sepsis syndrome and the frequency of the main a subgroup including only 18% of those with sepsis syndrome was identified, which included 68% of the episodes of fungemia subtypes that may be targeted by novel therapies. We also derived and validated clinical prediction rules for bloodstream in the validation set; in the remainder of the episodes, the probability of fungemia was only Ç2%. The rule for graminfections for these outcomes. The rule for bacteremia of any type performed well in that it achieved a 4-fold difference positive bacteremia performed poorly; however, the rule predicting S. aureus bacteremia performed better. The 2 lowestin percent risk between the highest-and lowest-risk groups, although 26% of bloodstream infections fell into the 2 lowestrisk groups included 85% of the validation set and had a proba- Figure 3 . Observed vs. predicted probability of positive result for 4 prediction models in study to determine prediction rules for bacteremia in sepsis. Each represents mean probability for subgroup of study patients, as defined using Hosmer and Lemeshow goodness-of-fit test. Dashed line corresponds to perfect agreement between observed and predicted values.
bility of S. aureus bacteremia of only 3%, while the higherphysicians remember these rules and of making them available when needed [30] . Fundamental to the clinical utility of the risk groups had probabilities of 19% and 33%.
Important proportions of cases for all the rules fall into rules is whether the degree of stratification that has been achieved crosses a threshold that affects clinical decision-makthe group at low risk of bacteremia. This suggests that other information, specifically new rapid diagnostic tests, which eiing. Clinical decision thresholds are a function of the clinical benefits and risks and of the financial costs of treatment stratether suggest the presence of a specific infection or identify an episode as particularly likely to result in an adverse outcome, gies and the probability of their occurrence. Patient preferences also affect these decisions. Such issues are complex, and the may be useful. This information can be used in conjunction with these or similar rules that use readily available clinical answers are often not evident a priori; they can best be resolved by use of modeling or formal decision analysis [31] . When information to stratify patients according to likelihood of subtypes of bacteremia.
Schulman et al. [32] performed a simulated analysis of the cost-effectiveness of a monoclonal anti-endotoxin antibody, The clinical utility of these rules remains to be determined. Clinical prediction rules in general have not received as much they used a base case probability of 36% for gram-negative bacteremia, which was present only in the highest-risk group use as might be expected [29] , although the increasing use of computers in medicine offers a promising way of helping in this study. With that probability, the novel therapy appeared cost-effective. However, as the probability of gram-negative sive therapy, and hospitalization in an ICU. Some factors important in the United States were not found in Israel (e.g., bacteremia fell, cost-effectiveness worsened asymptotically, suggesting that use of this agent under their other assumptions Israeli surgeons did not perform blood cultures in patients with an acute abdomen and there was little intravenous drug abuse). would not have been cost-effective.
Another key issue is whether the presence of documented In this analysis, we included only patients with sepsis syndrome, so factors such as tachycardia were present to some bacteremia is the outcome that should be predicted [9] . There are some patients, for example with intraabdominal sepsis, who degree in all patients. Independent predictors of any bacteremia were presence of a suspected or documented infection at sepsis never have positive blood cultures, yet who have adverse outcomes that are clearly related to sepsis. In addition, the prior onset, absence of antibiotic therapy at onset, liver disease, presence of a Hickman catheter, altered mental status, and focal use of antibiotic therapy affected the likelihood of obtaining a positive blood culture in this study, although it has not always abdominal signs. This rule performed well in both the derivation and validation sets, with one limitation being that the in other studies [16] ; the extent to which this is a problem cannot be determined because false-negative blood cultures middle group, which comprised about one-third of each set, had a probability of bacteremia similar to that of the entire cannot currently be identified. Advantages of using bacteremia as an outcome are that it is relatively reliable compared with cohort.
Although there are thousands of publications regarding inclinical judgments and it allows grouping of patients by the type of organism present. Other approaches include developing fections caused by gram-positive organisms, we could not identify another study in which a clinical prediction rule targeting rules to predict infection-related outcomes, such as specific types of organisms (independent of bacteremia), or other outgram-positive bacteremia as a group was developed. One reason, for example, may be that within the gram-positive bacteria, comes, such as organ failure [9] , short-or long-term mortality, and quality of life.
there is more heterogeneity between the infections caused by the main pathogens -Staphylococcus epidermidis, S. aureus, A number of previous studies have attempted to develop indices to predict bacteremia of all causes in hospitalized paStreptococcus pneumoniae, and enterococci -than between gram-negative organisms. However, it is possible that novel tients with sepsis [14] and in other hospitalized patients who have blood cultures performed [16, 17, 33] . Most studies have therapies will be developed that are effective against these organisms as a group. Neither of the variables with an indepenincluded data from only a single institution, a fact that raises questions about whether the results can be generalized. In addident predictor -intravenous drug abuse or suspected or documented focal infection with gram-positive organisms at onsettion, many randomized trials have reported the frequency of bacteremia of different types, although the patients in these was surprising. Although this rule identified a small group at high risk of gram-positive bacteremia, most of the episodes of studies were highly selected and may not be representative of all hospitalized patients with sepsis [34] . In a population of bacteremia fell into the remaining groups. Because this rule performed poorly, we developed and valipatients at VA Medical Centers, Peduzzi et al. [14] found that elevated temperature, low systolic blood pressure, and low dated a rule predicting S. aureus bacteremia. Intravenous drug abuse did not enter the model because it was closely related to platelet count were independently predictive of bacteremia, although these factors did not predict bacteremia with sufficient suspected staphylococcal infection. This rule performed much better, although still only 47% of the cases in the derivation accuracy to be clinically helpful.
We previously [16] found in a cohort of hospitalized patients set fell within the 2 highest-risk groups. Taken together, the above data suggest that rapid diagnostic laboratory tests may who had blood cultures performed that elevated temperature, rapidly or ultimately fatal disease, shaking chills, intravenous be particularly useful for patients with suspected gram-positive bacteremia. drug abuse, acute abdomen on examination, and major comorbidity were independent predictors of bacteremia. These factors Gram-negative bacteremia has received a great deal of attention recently because of its high morbidity and mortality and were used to develop a prospectively validated clinical prediction rule that stratified patients into groups with a probability because many of the novel therapies -notably anti-endotoxin antibodies -would be expected to be effective against this of bacteremia ranging from 2% to 14% in the validation set. However, when Imperiale et al. [35] attempted to validate this group of organisms [36 -38] . The trials have reported a prevalence of gram-negative bacteremia of about 40% [37 -38] . The rule in another institution, there was significant degradation in performance, particularly in the low-risk group, with a probahighest-risk groups we could identify in the derivation set had bacteremia rates of 20% and 42%, and in the validation set, bility of bacteremia ranging from 6% to 15%. They also developed and validated another rule, using hypotension, pulse these figures were 33% and 25%; combined, these groups made up 12% of the episodes. These data suggest that the patients §120, band count ú20%, significant bacteriuria, and not receiving antibiotics as risk factors [17] .
enrolled in the trials to date have been very highly selected and that they represent, at most, 12% of patients with sepsis In an analysis from Israel, Mozes et al. [33] found independent predictors of bacteremia to be temperature of §39ЊC, syndrome. In fact, 52% of the validation set patients with sepsis syndrome fell into a group with only a 6% risk of gram-negative elevated serum alkaline phosphatase, current immunosuppres-bacteremia. The factors we identified as predictive of gramat high risk of infection by specific types of organisms. When novel therapies become available, as seems likely, these models negative bacteremia included use of total parenteral nutrition, absence of antibiotic therapy at onset, history of gram-negative may also help providers stratify patients according to their risk of infection by specific organism type. Such models will bacteremia, presence of a Hickman catheter, focal abdominal signs, and chills. This rule may be useful in future trials.
probably eventually be most useful when used in conjunction with rapid diagnostic tests, either for mediators of sepsis or for Although there have been many case series of patients with fungemia [39 -41], we identified only three previous studies the organisms themselves. that included controls and evaluated predictors of fungemia [15, 42, 43] . In a case control study, Wey et al. [15] studied
